Rosie O'Donnell recently relocated to Ireland with her her 12-year-old child, Clay, and with her new home comes a new journey ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Last month, the U.S. Food and Drug Administration (the “FDA”) announced in a Declaratory Order the resolution of the shortage of semaglutide ...

A coalition of over 20 leading health organizations is calling on the U.S. Food & Drug Administration (FDA) to enforce federal regulations on compounded we ...

Rosie O'Donnell said she’s lost more weight since taking Mounjaro for her diabetes, admitting that she feels healthier and her new clothing size is “shocking.” ...

Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...

In a study in the journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for cardiovascular ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Mounjaro and Trulicity are two injectable medications that treat type 2 diabetes. Learn more about their key similarities, ...

In a new study in the peer-reviewed journal Diabetes Technology & Therapeutics (DTT), investigators evaluated biomarkers for ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

Tirzepatide and semaglutide offer long-term health benefits but are not cost-effective, according to a study publi ...